Corcept Therapeutics specializes in cortisol-modulating drugs. Click here to read why CORT stock offers investment potential.

In what the HSA described in a Nov 27 statement as a “first-of-its-kind large-scale collaboration with online platform ...

These are option for when two or more potential donors aren't compatible with their friend or family member and donate their ...

Dear D.B.: This is a very touching story, and I hope to help readers understand a few points. Autosomal dominant polycystic ...

This is a very touching story, and I hope to help readers understand a few points. Autosomal dominant polycystic kidney ...

I read your recent column on transplants and dialysis. Fifteen years ago, I found I had polycystic kidney disease and was ...

In another instance of don't take health advice from influencers on TikTok, the recent trend “#cortisolface” has gained ...

I read your recent column on transplants and dialysis. Fifteen years ago, I found I had polycystic kidney disease and was recommended a transplant. My wife and I discovered that our blood types were ...

Natixis Advisors LLC boosted its position in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) by 36.2% ...

2-Year U.S. Treasury Note Continuous Contract $102.750 0.059 0.06% 5-Year U.S. Treasury Note Continuous Contract $107.133 0.180 0.17% 10-Year U.S. Treasury Note Continuous Contract $110.609 0.281 ...